UK CHMP member Ian Hudson to replace Kent Woods as MHRA chief executive
Dr Ian Hudson is to replace Kent Woods as chief executive of Britain's Medicines and Healthcare Products Regulatory Agency (MHRA), it was announced on Thursday.
He will take over the role - one of the most senior in European, or global, regulation - in September when Woods steps down, the Department of Health said in a statement.
Hudson is MHRA Licensing Director as well as the UK's representative on the European Medicines Agency's CHMP scientific committee, on which he holds the position of vice-chairman.
An MHRA spokesman told APM Hudson would step down from these roles by September and a replacement will be confirmed by this date.
According to a brief CV attached to the statement, Hudson is a paediatrician who had a few years working in the pharmaceutical industry ahead of moving towards regulation for the state side.
Kent Woods is the European Medicines Agency's management board chairman and a spokeswoman for the agency confirmed to APM that he would remain in that post.